Fei Peng
Director of Finance/CFO at Beijing Biostar Pharmaceuticals Co. Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Li Tang | M | 61 |
Beijing Biostar Pharmaceuticals Co. Ltd.
 Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 years |
| Kai Lin Liu | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 4 years |
| Quan Zhou | F | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 15 years |
| Rong Guo Qiu | M | 62 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 22 years |
| Li Xin Wang | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
| Dong Ran | M | 38 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 1 years |
| Cheng Zhang | M | 49 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 6 years |
| Song Dong Meng | M | 54 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
| Shu Feng Zhang | M | 55 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 8 years |
| Ri Xiang Kong | M | 47 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 21 years |
| Yik Pun Chan | M | 42 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | - |
| Hong Luo | M | 53 |
Southwestern University of Finance & Economics
| 18 years |
| Ying Pan | M | 51 |
Southwestern University of Finance & Economics
| 19 years |
| Pai Zhu | M | 31 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
| Yong Qiang Ma | M | 49 |
Southwestern University of Finance & Economics
| 18 years |
| Heng Xie | M | 65 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 2 years |
| Hong Tao Mao | M | 54 |
Southwestern University of Finance & Economics
| 19 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Geng Chen | M | 51 |
Southwestern University of Finance & Economics
| 4 years |
| Zhi Bin Wang | M | 56 |
Southwestern University of Finance & Economics
| 4 years |
| Xiang Dong He | M | 43 |
Southwestern University of Finance & Economics
| 4 years |
| Yi Jian Huang | M | 45 |
Southwestern University of Finance & Economics
| 4 years |
| Jin Qiu Hua | M | 50 |
Southwestern University of Finance & Economics
| 5 years |
| Guan Jun Tian | M | 50 |
Southwestern University of Finance & Economics
| 6 years |
| Qiang Huang | M | 47 |
Southwestern University of Finance & Economics
| 5 years |
| Zhu Jin Wang | M | 60 |
Southwestern University of Finance & Economics
| 4 years |
| Yao Qiu Wang | M | 56 |
Southwestern University of Finance & Economics
| 4 years |
| Feng Lai Yang | M | - |
Southwestern University of Finance & Economics
| 1 years |
| Tao Zhou | F | 45 |
Southwestern University of Finance & Economics
| 1 years |
| Li Hong Zhai | M | 55 |
Southwestern University of Finance & Economics
| 3 years |
| Fenglai Yang | M | 61 |
Southwestern University of Finance & Economics
| 1 years |
| Tian Chun Xu | M | 58 |
Southwestern University of Finance & Economics
| 3 years |
| Rong Chuan Chen | M | 47 |
Southwestern University of Finance & Economics
| 1 years |
| Yong Ren | M | 41 |
Southwestern University of Finance & Economics
| 4 years |
| Kexi Zhao | M | 48 |
Southwestern University of Finance & Economics
| 4 years |
| Jin Kang Gao | M | 60 |
Southwestern University of Finance & Economics
| 3 years |
| Jian Chen | M | - |
Southwestern University of Finance & Economics
| 4 years |
| Xiaoya Wu | M | 51 |
Southwestern University of Finance & Economics
| 4 years |
| Guang Wei Huang | M | 60 |
Southwestern University of Finance & Economics
| 4 years |
| Fei Yang Zhang | F | 43 |
Southwestern University of Finance & Economics
| 4 years |
| Yu Peng Li | M | 41 |
Beijing Biostar Pharmaceuticals Co. Ltd.
Beijing Biostar Pharmaceuticals Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Biostar Pharmaceuticals Co. Ltd. engages in the tumor treatment. The company focuses on the development of new anti-cancer drugs with independent intellectual property rights. Its product Utidelone injection is the new-generation microtubule inhibitor produced by microbial fermentation process. The company was founded by Li Tang and Rong Guo Qiu on July 11, 2002 and is headquartered in Beijing, China. | 3 years |
| Dakun Shu | M | 57 |
Southwestern University of Finance & Economics
| 1 years |
| Tianyu Long | M | 39 |
Southwestern University of Finance & Economics
| 4 years |
| Lin Ping Li | F | 52 |
Southwestern University of Finance & Economics
| 2 years |
| Yan Xiao Wang | F | 45 |
Southwestern University of Finance & Economics
| 3 years |
| Yu Shen | M | 43 |
Southwestern University of Finance & Economics
| 3 years |
| Lun Gang Wang | M | 54 |
Southwestern University of Finance & Economics
| 3 years |
| Xiang Yu Chen | M | 35 |
Southwestern University of Finance & Economics
| 4 years |
| Ying Ma | M | 52 |
Southwestern University of Finance & Economics
| 2 years |
| Hong Kun Li | M | 55 |
Southwestern University of Finance & Economics
| 3 years |
| Yan Xi Peng | F | 37 |
Southwestern University of Finance & Economics
| 4 years |
| Li Cai | M | 40 |
Southwestern University of Finance & Economics
| 4 years |
| Li Wang | M | 45 |
Southwestern University of Finance & Economics
| 1 years |
| Jianfeng Xu | M | 54 |
Southwestern University of Finance & Economics
| 4 years |
| Jie Zhang | M | 38 |
Southwestern University of Finance & Economics
| 4 years |
| Sheng Tan | M | 55 |
Southwestern University of Finance & Economics
| 4 years |
| Gui Yan Zhao | F | 42 |
Southwestern University of Finance & Economics
| 4 years |
| Li Zeng | F | 46 |
Southwestern University of Finance & Economics
| 4 years |
| Ming Song Zhu | M | 62 |
Southwestern University of Finance & Economics
| 3 years |
| Xie Min Hao | M | 42 |
Southwestern University of Finance & Economics
| 4 years |
| Ying Zhou | F | 41 |
Southwestern University of Finance & Economics
| 4 years |
| Jun Liu | M | 42 |
Southwestern University of Finance & Economics
| 4 years |
| Minghua Zhao | M | - |
Southwestern University of Finance & Economics
| 4 years |
| Wang Bin | M | 59 |
Southwestern University of Finance & Economics
| 3 years |
| Wei Dong Huo | M | 54 |
Southwestern University of Finance & Economics
| 3 years |
| Wei Min Gan | M | 57 |
Southwestern University of Finance & Economics
| 1 years |
| Yi Fan Li | M | 45 |
Southwestern University of Finance & Economics
| 4 years |
| Li Kang | F | 45 |
Southwestern University of Finance & Economics
| 1 years |
| Guo Qiong Tang | M | 61 |
Southwestern University of Finance & Economics
| - |
| Ren Ping Wang | M | 54 |
Southwestern University of Finance & Economics
| 3 years |
| Bing Jian Wu | M | 63 |
Southwestern University of Finance & Economics
| 4 years |
| Hong Chen | F | 44 |
Southwestern University of Finance & Economics
| 3 years |
| Xing Wang | M | 59 |
Southwestern University of Finance & Economics
| 3 years |
| Dan Zhou Wang | M | 60 |
Southwestern University of Finance & Economics
| 3 years |
| Jian Hua Xu | M | 62 |
Southwestern University of Finance & Economics
| 3 years |
| Hai Zong Yu | M | 60 |
Southwestern University of Finance & Economics
| 3 years |
| Jun Huai Zhao | M | 57 |
Southwestern University of Finance & Economics
| 3 years |
| Hong Pu | M | 62 |
Southwestern University of Finance & Economics
| 4 years |
| Wen Feng Huang | M | 59 |
Southwestern University of Finance & Economics
| 4 years |
| Gang Qiang Liu | M | 50 |
Southwestern University of Finance & Economics
| 3 years |
| Hai Tao Wu | M | 48 |
Southwestern University of Finance & Economics
| 2 years |
| Meng Zhang | M | 61 |
Southwestern University of Finance & Economics
| 3 years |
| Nai Ling Xu | F | 58 |
Southwestern University of Finance & Economics
| 4 years |
| Ri Xin Hua | F | 64 |
Southwestern University of Finance & Economics
| 4 years |
| Yong Li Liu | F | 53 |
Southwestern University of Finance & Economics
| 4 years |
| Qi Zhang | M | 50 |
Southwestern University of Finance & Economics
| 2 years |
| Gang Chen | M | 54 |
Southwestern University of Finance & Economics
| 4 years |
| Jun Feng Wu | M | 51 |
Southwestern University of Finance & Economics
| 3 years |
| Da Yue Deng | M | 56 |
Southwestern University of Finance & Economics
| 3 years |
| Teng Wen Zhang | M | 54 |
Southwestern University of Finance & Economics
| 3 years |
| Ming An Gu | M | 58 |
Southwestern University of Finance & Economics
| 3 years |
| Hong Yan | M | 50 |
Southwestern University of Finance & Economics
| 1 years |
| Pei Peng | M | 51 |
Southwestern University of Finance & Economics
| 4 years |
| Yue Wu | F | 45 |
Southwestern University of Finance & Economics
| - |
| Qing Yang | F | 59 |
Southwestern University of Finance & Economics
| 1 years |
| Yuan Feng | F | 53 |
Southwestern University of Finance & Economics
| 1 years |
| Jie Min Pang | M | 53 |
Southwestern University of Finance & Economics
| 3 years |
| Yue Wen Li | M | 45 |
Southwestern University of Finance & Economics
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| China | 97 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Fei Peng
- Personal Network
